NO910933D0 - Nytt pentapeptid og fremgangsmaate for fremstilling derav. - Google Patents

Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Info

Publication number
NO910933D0
NO910933D0 NO910933A NO910933A NO910933D0 NO 910933 D0 NO910933 D0 NO 910933D0 NO 910933 A NO910933 A NO 910933A NO 910933 A NO910933 A NO 910933A NO 910933 D0 NO910933 D0 NO 910933D0
Authority
NO
Norway
Prior art keywords
new
pentapeptime
preparing
procedure
pentapeptide
Prior art date
Application number
NO910933A
Other languages
English (en)
Other versions
NO910933L (no
Inventor
Jan Erik Paulsen
Karl-Ludvig Reichelt
Original Assignee
Hafslund Nycomed Bioreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Bioreg filed Critical Hafslund Nycomed Bioreg
Priority to NO910933A priority Critical patent/NO910933D0/no
Publication of NO910933L publication Critical patent/NO910933L/no
Publication of NO910933D0 publication Critical patent/NO910933D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO910933A 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav. NO910933D0 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO910933A NO910933D0 (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.
PCT/NO1989/000093 WO1990002754A1 (en) 1988-09-13 1989-09-12 New pentapeptide and a process for the preparation thereof
NO910933A NO910933D0 (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Publications (2)

Publication Number Publication Date
NO910933L NO910933L (no) 1991-03-08
NO910933D0 true NO910933D0 (no) 1991-03-08

Family

ID=19891239

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.
NO910933A NO910933D0 (no) 1988-09-13 1991-03-08 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884054A NO884054D0 (no) 1988-09-13 1988-09-13 Nytt pentapeptid og fremgangsmaate for fremstilling derav.

Country Status (19)

Country Link
EP (2) EP0434722A1 (no)
JP (1) JPH04501710A (no)
KR (1) KR900701830A (no)
CN (1) CN1041158A (no)
AT (1) ATE102215T1 (no)
AU (1) AU623687B2 (no)
DE (1) DE68913411T2 (no)
DK (1) DK43891A (no)
ES (1) ES2062024T3 (no)
FI (1) FI911219A0 (no)
HU (2) HU895790D0 (no)
LV (1) LV10289B (no)
MD (1) MD503C2 (no)
MY (1) MY104912A (no)
NO (2) NO884054D0 (no)
NZ (1) NZ230625A (no)
RU (1) RU2010799C1 (no)
WO (1) WO1990002754A1 (no)
ZA (1) ZA896944B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
TW222280B (no) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
RU2297239C1 (ru) * 2006-05-30 2007-04-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591748A (en) 1949-12-23 1952-04-08 Hercules Powder Co Ltd Amphoteric cellulose derivatives
FR2110268B1 (no) 1970-10-07 1976-06-04 Minnesota Mining & Mfg
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
NO884054D0 (no) 1988-09-13
HU206373B (en) 1992-10-28
LV10289A (lv) 1994-10-20
MY104912A (en) 1994-06-30
EP0360481A1 (en) 1990-03-28
DE68913411T2 (de) 1994-06-23
FI911219A0 (fi) 1991-03-12
DK43891D0 (da) 1991-03-12
EP0434722A1 (en) 1991-07-03
ES2062024T3 (es) 1994-12-16
DK43891A (da) 1991-03-12
NO910933L (no) 1991-03-08
HUT58766A (en) 1992-03-30
MD503B1 (en) 1996-03-29
ZA896944B (en) 1990-06-27
LV10289B (en) 1995-04-20
CN1041158A (zh) 1990-04-11
MD503C2 (ro) 1996-07-31
HU895790D0 (en) 1991-11-28
AU4224089A (en) 1990-04-02
RU2010799C1 (ru) 1994-04-15
ATE102215T1 (de) 1994-03-15
EP0360481B1 (en) 1994-03-02
JPH04501710A (ja) 1992-03-26
AU623687B2 (en) 1992-05-21
DE68913411D1 (de) 1994-04-07
KR900701830A (ko) 1990-12-04
NZ230625A (en) 1991-06-25
WO1990002754A1 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
GR78722B (no)
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
CA2015186A1 (en) Nutrient composition
MY102280A (en) 6-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5- tetrahydropyridazin-3-ones
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
AU591772B2 (en) Substituted oxime-ethers and their use as bioregulators to lower the endogenous ethylene level in plants
MY132057A (en) Quinoxalinones, a process for their preparation and their use
DE69118064D1 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
NO910933D0 (no) Nytt pentapeptid og fremgangsmaate for fremstilling derav.
DK0535104T3 (da) Heterocyliske forbindelser deres fremstilling og anvendelse
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
MY131054A (en) "piperazine cyanurate and polymer compositions comprising it"
MY105072A (en) Substituted alkenes, processes for their preparation and their use as pesticides.
WO1990010006A3 (de) NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
FI852990A0 (fi) Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat.
ATE90942T1 (de) (3-diethylaminopropyl)-1-amino-5methyldipyrido(4,3-b>(3,4-f>indoltrihydrochlori .